Treatment of localized esophageal cancer

被引:62
作者
Brenner, B
Ilson, DH
Minsky, BD
机构
[1] Rabin Med Ctr, Inst Oncol, IL-49100 Petah Tiqwa, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Cornell Univ, Med Ctr, Dept Med, Gastrointestinal Oncol Serv, New York, NY 10021 USA
[4] Cornell Univ, Med Ctr, Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10021 USA
[5] Cornell Univ, Weill Sch Med, New York, NY USA
关键词
D O I
10.1053/j.seminoncol.2004.04.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The treatment of localized esophageal cancer (LEC) is controversial. The approaches that are used in daily practice include surgery or radiation alone, preoperative or postoperative radiation, preoperative or postoperative chemotherapy, and definitive or preoperative chemoradiation. The varied modalities used to treat LEC reflect both the lack of randomized trial data and the suboptimal results with current therapy. Nonetheless, the available data suggest that surgery and definitive concurrent chemoradiation represent two standard treatment options. The use of preoperative chemoradiation remains investigational, with phase III trials failing to demonstrate a consistent benefit for this option over chemoradiation or surgery alone. This review will examine the available data on the current treatment approaches in LEC. © 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:554 / 565
页数:12
相关论文
共 95 条
  • [1] PROLONGED CHEMOTHERAPY FOR LOCALIZED SQUAMOUS CARCINOMA OF THE ESOPHAGUS
    AJANI, JA
    RYAN, B
    RICH, TA
    MCMURTREY, M
    ROTH, JA
    DECARO, L
    LEVIN, B
    MOUNTAIN, C
    [J]. EUROPEAN JOURNAL OF CANCER, 1992, 28A (4-5) : 880 - 884
  • [2] Ajani JA, 2001, CANCER-AM CANCER SOC, V92, P279, DOI 10.1002/1097-0142(20010715)92:2<279::AID-CNCR1320>3.0.CO
  • [3] 2-2
  • [4] ALLUM W, 2003, P AN M AM SOC CLIN, V22, P249
  • [5] Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study
    AlSarraf, M
    Martz, K
    Herskovic, A
    Leichman, L
    Brindle, JS
    Vaitkevicius, VK
    Cooper, J
    Byhardt, R
    Davis, L
    Emami, B
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 277 - 284
  • [6] Altorki N K, 1999, Surg Oncol Clin N Am, V8, P295
  • [7] ANDERSON S, 2001, P AN M AM SOC CLIN, V20, pA158
  • [8] Ando N, 1999, P AN M AM SOC CLIN, V18, p269a
  • [9] ARAUJO CMM, 1991, CANCER, V67, P2258, DOI 10.1002/1097-0142(19910501)67:9<2258::AID-CNCR2820670908>3.0.CO
  • [10] 2-G